SCHEMBL19803934

SCHEMBL19803934

CC(c1ccc(-c2ccccc2)cc1)(c1c(O)ccc2ccccc12)c1c(O)ccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.42
▸ ESR2 Q92731 3/20 0.42
▸ PTPN22 Q9Y2R2 1/20 0.42
▸ HSD17B2 P37059 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ HSD17B10 Q99714 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ PAK1 Q13153 1/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861559 0.97 PTPN22 (0.44) ESR1ESR2PTPN22HSD17B2THRB
SCHEMBL23861563 0.92 PTPN22 (0.48) ESR1ESR2PTPN22HSD17B2THRB
SCHEMBL23861443 0.90 ESR1 (0.47) ESR1ESR2PTPN22HSD17B2THRB
SCHEMBL19806874 0.90 ESR1 (0.38) ESR1ESR2PTPN22HSD17B2THRB
SCHEMBL23082042 0.87 ESR1 (0.48) ESR1ESR2HSD17B2POLBGAA
SCHEMBL23082053 0.85 ESR1 (0.54) ESR1ESR2HSD17B2CYP1A2CYP2C9
SCHEMBL19803933 0.83 ESR1 (0.45) ESR1ESR2HSD17B2CYP1A2CYP2C9
SCHEMBL23861638 0.83 POLB (0.44) ESR1ESR2PTPN22HSD17B2THRB
SCHEMBL19806848 0.80 ESR1 (0.42) ESR1ESR2HSD17B2CYP1A2CYP2C9
SCHEMBL23861411 0.79 ESR1 (0.41) ESR1ESR2HSD17B2HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed
US-20210070683-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed
US-20210070685-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed
US-10723690-B2 (Meth)acryloyl compound and method for producing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-07-28 — — US disclosed
US-20180210341-A1 NOVEL (METH)ACRYLOYL COMPOUND AND METHOD FOR PRODUCING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-07-26 — — US disclosed
US-20180210341-A1 NOVEL (METH)ACRYLOYL COMPOUND AND METHOD FOR PRODUCING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-07-26 — — US disclosed
EP-3326997-A1 NEW (METH)ACRYLOYL COMPOUND AND PRODUCTION METHOD FOR SAME Mitsubishi Gas Chemical Company, Inc. (JP) 2018-05-30 — — EP disclosed
WO-2018016615-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, AND CIRCUIT PATTERN FORMATION METHOD 三菱瓦斯化学株式会社 2018-01-25 — — WO disclosed
WO-2018016640-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, AND CIRCUIT PATTERN FORMATION METHOD 三菱瓦斯化学株式会社 2018-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070683-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD RER1, RTN4, FEM1B ESR1 1539/4885ESR2 2068/4885PTPN22 3135/4885
US-20180210341-A1 NOVEL (METH)ACRYLOYL COMPOUND AND METHOD FOR PRODUCING SAME MTR, MRM1, MT-CO1 ESR1 2134/4885ESR2 2091/4885PTPN22 2283/4885
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD RDX, RTN4, CROCC ESR1 1453/4885ESR2 1492/4885PTPN22 4544/4885
US-10723690-B2 (Meth)acryloyl compound and method for producing same MTR, MRM1, MT-CO1 ESR1 2071/4885ESR2 2182/4885PTPN22 2048/4885
US-20210070685-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD RER1, RTN4, FEM1B ESR1 1539/4885ESR2 2068/4885PTPN22 3135/4885
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR1 713/4885ESR2 1033/4885PTPN22 2079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback